Sign up now and fund within 24h to get A$10.
Claim It Now
Stake logo
LoginOpen an accountSign up
​

ACL

Trade Now
Compare

Australian Clinical Labs Limited

$3.120

+$0.01 (+0.32%) Day

1 day chart

Created with Highcharts 11.1.0
10:0011:0012:0013:0014:0015:0016:00
3.083.13.123.143.163.18
Get A$10 trading credit to start you off

Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.

Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.

T&Cs apply
Claim now
Get A$10 trading credit to start you off

About ACL

Australian Clinical Labs (ACL) is a Company engaged in provision of pathology diagnostic services.

Find out what a historical investment in Australian Clinical Labs Limited would be worth today using our ACL stock calculator.

Sector

Health Care

CEO

-

Industry

Health Care Providers & Services

Website

clinicallabs.com.au

Market Capitalisation

$620M

Price-earnings ratio

25.92

Dividend yield

4.02%

High today

$3.16

Low today

$3.10

Open price

$3.10

52-week high

$3.86

52-week low

$2.14

Ready to start your investing journey with Stake?

Open an account

Announcements

Notification of cessation of securities - ACL

Wed, Apr 30, 2025

Final Director's Interest Notice - M Alscher

Wed, Apr 30, 2025

Update - Notification of buy-back - ACL

Tue, Apr 29, 2025

ACL FAQs

Buying ACL shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Australian Clinical Labs Limited in minutes.
  1. Sign up with some I.D. and zero paperwork
  2. Add funds to your account
  3. Make your first investment in ACL
The ticker symbol for Australian Clinical Labs Limited is ACL.
One share of ACL is valued at $3.12 as of 30 April 2025.
As of 30 April 2025 Australian Clinical Labs Limited has a market cap of $620M.
ACL stock is currently +4.70% over the last month. Whether or not ACL is a good buy depends on your investing goals and strategy. It's essential to conduct thorough research on Australian Clinical Labs Limited to see if it suits your investment portfolio.
Yes, ACL does pay dividends.
The dividend yield for ACL is 4.02% as of 30 April 2025.
The most recent ACL dividend distribution paid $0.04 per share on 16 April 2025.
The ex-dividend date of ACL was 27 March 2025.
The Price to Earnings ratio of ACL is 25.92.
The Earnings Per Share of ACL is $0.12.
The Australian Clinical Labs Limited 52-week high stock price is $3.86.
The Australian Clinical Labs Limited 52-week low stock price is $2.14.
Yes, the Stake investing platform allows you to buy ACL shares and over 12,000 more stocks and ETFs across the ASX and Wall St.

This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in ACL
on Stake

Buy ACL from A$3 brokerage

Invest in 2,500+ Aussie stocks and ETFs

CHESS-sponsored ASX trades

Get started
Stake app chart
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
ACL related stocks
M

Microba Life Sciences Limited

MAP

-24.44%

S

Sonic Healthcare Limited

SHL

-0.15%

H

Healius Limited

HLS

+1.04%

I

Integral Diagnostics Limited

IDX

+2.11%

R

Rhythm Biosciences Limited

RHY

-8.96%

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Investing

Product

Account

Learn

Company

Legal

Contact Us

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.
Region: au
Stakeshop Pty Ltd, trading as Stake, ACN 610 105 505, is an authorised representative (Authorised Representative No. 1241398) of Stakeshop AFSL Pty Ltd (Australian Financial Services Licence no. 548196). Stake SMSF Pty Ltd ACN 648 283 532 (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. For more information about SMSFs, see our SMSF Risks page. The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services Guide, Terms & Conditions, Privacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2025 Stake. All rights reserved.

This site uses cookies. By using our site you agree to the Stake Privacy Policy.